Advertisement

Letter to the Editor in Response to a Recent Commentary, “Mammography Trials” by Drs. Saurabh Jha and Jeffrey B. Ware

Published:October 27, 2015DOI:https://doi.org/10.1016/j.acra.2015.08.029
      As a physician who takes care of women with breast cancer, and as a breast cancer advocate, I strongly disagree with the Drs. Jha and Ware's commentary entitled “Mammography Trials.” The commentary contains multiple inaccurate statements about screening mammography. Drs. Jha and Ware's most egregious is their opening statement, “There is so much uncertainty precisely because the benefits are so small at the population level.” Their limited review of mammography trials focuses solely on the Canadian National Breast Screening Study (CNBSS). They have chosen to ignore the results of all the other randomized clinical trials (RCTs).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Academic Radiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Smith R.A.
        • Duffy S.W.
        • Gabe R.
        • et al.
        The randomized trials of breast cancer screening: what have we learned?.
        Radiol Clin North Am. 2004; 42: 793-806
        • Tabár L.
        • Fagerberg C.J.
        • Gad A.
        • et al.
        Reduction in mortality from breast cancer after mass screening with mammography: randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare.
        Lancet. 1985; 1: 829-832
        • Tabár L.
        • Vitak B.
        • Chen T.H.
        • et al.
        Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades.
        Radiology. 2011; 260: 658-663
        • Gøtzsche P.C.
        • Olsen O.
        Is screening for breast cancer with mammography justifiable?.
        Lancet. 2000; 355: 129-134
        • Coldman A.
        • Phillips N.
        • Wilson C.
        • et al.
        Pan-Canadian study of mammography screening and mortality from breast cancer.
        J Natl Cancer Inst. 2014; 106: dju261